Precirix

Investment area
Seed Investments
Region
Europe
Date of investment
November 2018

Precirix is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.

Precirix

Investment area
Seed Investments
Region
Europe
Date of investment
November 2018

Precirix is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.

Precirix

Investment area
Seed Investments
Region
Europe
Date of investment
November 2018

Precirix is a clinical-stage biotechnology company dedicated to improving the lives of cancer patients by developing novel targeted radiopharmaceuticals using camelid single domain antibody fragments.